VC Dekho
InvestorsFundsToolsUnlocked Emails
VC Dekho
VC Dekho
InvestorsFundsToolsUnlocked Emails
Sign inUnlock investor emails free
VC Dekho
←Back to Portfolio lookup
Home›Portfolio lookup›CureBay
01
Portfolio lookup

CureBay

1 fund on VC Dekho list CureBay in their portfolio · Healthcare · Series B.

1backing fund
Search another companyRank funds by stage & sector
Backing funds

Who backed CureBay

Venture Capital

Elevar Equity

Series B · $21.0M · 2025-05-20

$1M
Related

Related companies

Other startups sharing a backer, sector, or stage with CureBay.

Aye FinanceCredijustoHippo StoresInCredIndifiLEADNiroPeepul Tree
Widen the list

Funds with similar portfolios

Funds that don't back CureBay directly, but invest in similar sectors and stages.

Venture Capital

Accion Venture Lab

Fintech, Social Impact

$200K – $1M
Venture Capital

Astir Ventures

Sector Agnostic

Pre-Seed
Venture Capital

ITI Growth Opportunities

Consumer / D2C, Deep Tech

$100K – $600K
Venture Capital

Lok Capital

Fintech, Healthcare / Medtech, Edtech

$500K – $10M
Angel / Individual

Nandan Nilekani

Sector Agnostic

Pre-Seed, Series A
Venture Capital

Trifecta Capital

SaaS / Enterprise, Fintech, Consumer / D2C

$2M – $30M

Things to remember

FAQ

Coverage notes for CureBay and how to widen your search.

01How complete is the portfolio data?
VC Dekho tracks portfolio companies mentioned in fund profiles and public deal coverage. Coverage is incomplete and skews toward funds and deals with public disclosure, not a full cap table view.
02Can I search by sector instead of company name?
Not yet in this tool. Browse funds by sector or stage on the directory instead.
03How is this different from the investor matcher?
The investor matcher ranks funds by your stage, sector, and cheque size. Portfolio lookup starts from a company you already know and shows which funds backed it, plus funds with similar portfolio patterns.
04Does a listing mean the fund endorses my startup?
No. This only shows that a company appears in a fund's public portfolio or deal coverage. It is a research starting point, not an introduction or an endorsement.
Explore
Investor directoryFundsPre-seedSeedSeries APricing